R. Loch Macdonald - Apr 14, 2025 Form 4 Insider Report for Grace Therapeutics, Inc. (GRCE)

Role
Chief Medical Officer
Signature
/s/ Robert DelAversano as attorney-in-fact for R. Loch Macdonald
Stock symbol
GRCE
Transactions as of
Apr 14, 2025
Transactions value $
$0
Form type
4
Date filed
4/16/2025, 08:58 PM
Previous filing
May 8, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRCE Stock Option (Right to Buy) Award $0 +40K $0.00 40K Apr 14, 2025 Common Stock 40K $2.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests quarterly in substantially equal installments over a 3-year period, subject to the Reporting Person's continuous service as of each vesting date.

Remarks:

Exhibit 24: Power of Attorney